Form 4: Merck & Co. Director Mary Ellen Coe Reports Phantom Stock Acquisition

Director Mary Ellen Coe reports acquisition of phantom stock units convertible to common stock in a recent SEC filing.

Summary

• Mary Ellen Coe, a director at Merck & Co., Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of phantom stock units on September 30, 2024.
• These phantom stock units are convertible to common stock on a 1-for-1 basis.
• The reporting person acquired 264.1775 phantom stock units at a price of $113.56.
• The phantom stock units will be settled in cash upon the director's termination of service, according to a pre-elected distribution schedule.
• Following the reported transaction, the director beneficially owns 23,574.2221 shares of common stock, including shares acquired through dividend reinvestment transactions.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of phantom stock aligns the director's interests with the company's performance. The filing itself is a routine disclosure.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• Dividend reinvestment indicates a continued investment in the company's future.

Future Outlook

The phantom stock units will be settled in cash upon the director's termination of service, according to a pre-elected distribution schedule.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's continued investment in the company.

Key Dates